Quarterly report pursuant to Section 13 or 15(d)
Cover
Document and Entity Information
Financial Statements
Balance Sheets (Unaudited)
Balance Sheets (Unaudited) (Parenthetical)
Statements of Operations (Unaudited)
Statements of Stockholders' Equity (Unaudited)
Statements of Cash Flows (Unaudited)
Statements of Cash Flows - Non-Cash Activities (Unaudited) (Parenthetical)
Notes to Financial Statements
Organization, Description of Business and Liquidity and Capital Resources
Significant Accounting Policies
Clinical Trial and Sponsored Research Agreements
Related Party Agreements
Assets Purchase Agreements
Property, Plant and Equipment, and Asset Impairment
Accounts Payable and Accrued Expenses
Notes Payable
Stockholders' Equity
Net Loss per Share
Income Taxes
Commitments and Contingencies
Pay vs Performance Disclosure
Insider Trading Arrangements
Accounting Policies
Significant Accounting Policies (Policies)
Notes Tables
Significant Accounting Policies (Tables)
Clinical Trial and Sponsored Research Agreements (Tables)
Property, Plant and Equipment, and Asset Impairment (Tables)
Accounts Payable and Accrued Expenses (Tables)
Notes Payable (Tables)
Stockholders' Equity (Tables)
Net Loss per Share (Tables)
Commitments and Contingencies (Tables)
Notes Details
Organization, Description of Business and Liquidity and Capital Resources (Details)
Significant Accounting Policies (Cash, Cash Equivalents, and Restricted Cash) (Details)
Clinical Trial and Sponsored Research Agreements (Sponsored Research and Clinical Trial Agreements) (Details)
Clinical Trial and Sponsored Research Agreements (City of Hope - Sponsored Research and Clinical Trial Agreements) (Narrative) (Details)
Related Party Agreements (Narrative) (Details)
Assets Purchase Agreements (Details)
Property, Plant and Equipment, and Asset Impairment (Schedule of Property, Plant and Equipment) (Details)
Property, Plant and Equipment, and Asset Impairment (Narrative) (Details)
Accounts Payable and Accrued Expenses (Schedule of Accounts Payable and Accrued Expenses) (Details)
Notes Payable (Narrative) (Details)
Notes Payable - Interest Expense (Details)
Stockholders Equity (Registration Statements and At-the-Market Offering) (Details)
Stockholders' Equity - May 2024 Public Offering (Details)
Stockholders' Equity - June 2024 Registered Direct Offering (Details)
Stockholders Equity (Equity Incentive Plans and Employee Stock Purchase Plan) (Details)
Stockholders Equity (Stock Option Activities) (Details)
Stockholders Equity (Restricted Stock or Restricted Units Awards) (Details)
Stockholders Equity (Stock-based Compensation Expense) (Details)
Stockholders' Equity (Warrants Activity) (Details)
Net Loss per Share (Potentially Dilutive Securities) (Details)
Commitments and Contingencies (Narrative) (Details)
Commitments and Contingencies (Schedule of Operating Leases) (Details)
Commitments and Contingencies (Cash Flows) (Details)
Commitments and Contingencies (Maturities of Operating Leases) (Details)
Commitments and Contingencies (Schedule of Operating Leases) (Details)
403 Forbidden
Forbidden
You don't have permission to access this resource.